Metrics
189,636 Downloads
Contact Share
heiDATA is an institutional repository for Open Research Data from Heidelberg University. It is managed by Heidelberg University's Research Data Unit, a joint institution of the University Library and the Computing Centre. If you are interested in publishing your data here, please have a look at our user guide and get in touch with us. Detailed information on heiDATA can be found in our service description.
Featured Dataverses

In order to use this feature you must have at least one published dataverse.

Publish Dataverse

Are you sure you want to publish your dataverse? Once you do so it must remain published.

Publish Dataverse

This dataverse cannot be published because the dataverse it is in has not been published.

Delete Dataverse

Are you sure you want to delete your dataverse? You cannot undelete this dataverse.

Advanced Search

3,021 to 3,030 of 9,107 Results
Vardarli_Suppl. Table 12.pdf
Vardarli_Suppl. Table 12.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 219.2 KB - MD5: f9d8e1df71b9731cc42906df4abab368
Suppl. Table 12. Trim-and-fill results for trials investigating insulin-dependent diabetes mellitus grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 1.pdf
Vardarli_Suppl. Table 1.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 625.1 KB - MD5: 591d49eda306f69d5fd24a059d714ccc
Suppl. Table 1. Checklist according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) 2020 guidelines for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monoth...
Vardarli_Suppl. Table 2.pdf
Vardarli_Suppl. Table 2.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 363.9 KB - MD5: 7c1640658f8d06736e3dad712a927841
Suppl. Table 2. Search strategies for randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors.
Vardarli_Suppl. Table 3.xlsx
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
MS Excel Spreadsheet - 116.7 KB - MD5: 7b97c14d958dffb9cb3347b48fd10fba
Suppl. Table 3. Study characteristics of randomized controlled trials investigating endocrine adverse effects any grade and grade 3-5 after immune related checkpoint inhibitor monotherapy or combination therapy in solid tumors. NSCLC, Non-small cell lung cancer; LD-SCLC, Limited...
Vardarli_Suppl. Table 4.pdf
Vardarli_Suppl. Table 4.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 257.8 KB - MD5: d6acaa2141ff4cf50ded0d6820579aea
Suppl. Table 4. Frequencies of various parameters in included trials, n= 80 trials.
Vardarli_Suppl. Table 5.pdf
Vardarli_Suppl. Table 5.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 220.6 KB - MD5: 09b0b7b7245dcb116eb15df62fdef98d
Suppl. Table 5. Meta-regression for trials investigating hypothyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 6.pdf
Vardarli_Suppl. Table 6.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 220.7 KB - MD5: 30371284a775d08e7044c09b78aaeace
Suppl. Table 6. Meta-regression for trials investigating hyperthyroidism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 7.pdf
Vardarli_Suppl. Table 7.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 216.5 KB - MD5: c1e3211bc08d5e1fd11cb1ca68248762
Suppl. Table 7. Trim-and-fill results for trials investigating hypophysitis/hypopituitarism any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 8.pdf
Vardarli_Suppl. Table 8.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 218.9 KB - MD5: e32fa8cb72081403d574d4d1d280e827
Suppl. Table 8. Trim-and-fill results for trials investigating hypophysitis/hypopituitarism grade 3-5 after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Vardarli_Suppl. Table 9.pdf
Vardarli_Suppl. Table 9.pdf
Nov 25, 2023 - Risk and incidence of endocrine immune related adverse effects under checkpoint inhibitor mono or combination therapy in solid tumors: a meta-analysis of randomized controlled trials [data]
Adobe PDF - 216.7 KB - MD5: 78f6d13d435b94fe3733e03fdaf77c63
Suppl. Table 9. Trim-and-fill results for trials investigating adrenal insufficiency any grade after immune related checkpoint inhibitor therapy in solid tumors, n= 80 trials.
Add Data

Sign up or log in to create a dataverse or add a dataset.

Sign Up Log In
Share Dataverse

Share this dataverse on your favorite social media networks.

Link Dataverse
Reset Modifications

Are you sure you want to reset the selected metadata fields? If you do this, any customizations (hidden, required, optional) you have done will no longer appear.